FERNDEX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ferndex, and when can generic versions of Ferndex launch?
Ferndex is a drug marketed by Ferndale Labs and is included in one NDA.
The generic ingredient in FERNDEX is dextroamphetamine sulfate. There are eighteen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the dextroamphetamine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ferndex
A generic version of FERNDEX was approved as dextroamphetamine sulfate by BARR on January 31st, 2001.
Summary for FERNDEX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 18 |
Formulation / Manufacturing: | see details |
DailyMed Link: | FERNDEX at DailyMed |
US Patents and Regulatory Information for FERNDEX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ferndale Labs | FERNDEX | dextroamphetamine sulfate | TABLET;ORAL | 084001-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |